Sulzer, a Swiss industrial engineering and manufacturing firm, agreed to acquire Haselmeier, a privately held drug delivery device developer and manufacturer, for $118m. “We are excited to welcome the Haselmeier team into the APS family. Haselmeier has a successful track record of providing innovative drug delivery devices based on its proprietary IP business model. We believe that we will add to the success story by providing financial strength and precision injection molding capabilities, thereby accelerating the company’s growth. Furthermore, combining our expertise in liquid mixing applications with Haselmeier’s drug delivery competence, will benefit our pharmaceutical customers providing them with innovative and differentiated devices and services,” Girts Cimermans, Sulzer APS President.